Survey: Perception gap divides single-use, stainless camps

It sounds like a generational dispute, with parents only partially believing what the kids tell them. Some 35 percent of stainless steel bioprocess equipment users surveyed say they believe there's a cost advantage to all-disposable systems. Among those who actually use single-use technology, 54 percent are believers.

And nearly twice as many all-disposable users see a process reproducibility advantage over the all-stainless generation (31 to 18 percent), writes Pharmaceutical Technology editor Michelle Hoffman, citing results of an annual survey.

Another finding is that 20 percent of the stainless crowd sees increased contamination risk in all-disposable systems. Among the single-use users--zero percent.

- see the editorial

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.